Categories: EngineeringHumanPlatform
HERVolution Therapeutics is engineering novel immunotherapies that empower the immune system to target HERVs, a class of dark genome antigens impacting cancer as well as metabolic and aging-related diseases.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.12.2024 | Series A | $11.7M | - |
Mentions in press and media 3
| Date | Title | Description |
| 22.12.2024 | HERVolution Therapeutics: A New Dawn in Dark Genome Research | In the realm of biotechnology, innovation often dances in the shadows. HERVolution Therapeutics, a Copenhagen-based company, is stepping into the light with a bold mission. The company recently secured $11.7 million in Series A funding, a f... |
| 19.12.2024 | HERVolution Therapeutics Raises $11.7M in Series A Funding | HERVolution Therapeutics, a Copenhagen, Denmark-based dark genome-focused biotechnology company, raised $11.7M in Series A funding.
The round was led by Serum Institute of India (SII) with participation from the European Innovation Council ... |
| - | Hervolution Therapeutics | “HERVolution Therapeutics is engineering novel immunotherapies that empower the immune system to target HERVs, a class of dark genome antigens impacting cancer as well as metabolic and aging-related diseases.” |
Reviews 0
